All Stories

  1. Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine
  2. Medical, Genomic, and Evolutionary Aspects of the Peptide Sharing between Pathogens, Primates, and Humans
  3. Hydrophobicity and the Physico-Chemical Basis of Immunotolerance
  4. Immunobiology: on the inexistence of a negative selection process
  5. Human Papillomavirus Epitope Mimicry and Autoimmunity: The Molecular Truth of Peptide Sharing
  6. The comparative biochemistry of viruses and humans: an evolutionary path towards autoimmunity
  7. Inter-Pathogen Peptide Sharing and the Original Antigenic Sin: Solving a Paradox
  8. Cytomegalovirus Infection: The Neurodevelopmental Peptide Signatures
  9. Rare Human Codons and HCMV Translational Regulation
  10. Role of codon usage and tRNA changes in rat cytomegalovirus latency and (re)activation
  11. H1N1 versus H5N1 hemagglutinins: A possible differential immunologic impact on neurodevelopment
  12. Describing the Potential Crossreactome between Mumps Virus and Spermatogenesis-Associated Proteins
  13. The Peptide Network between Tetanus Toxin and Human Proteins Associated with Epilepsy
  14. Peptide matching between Epstein-Barr virus and human proteins
  15. Peptide sharing betweenBordetella pertussisproteome and human sudden death proteins: a hypothesis for a causal link
  16. Peptide profiling of the route from Mahoney to Sabin, and return
  17. Peptide Sharing Between Influenza A H1N1 Hemagglutinin and Human Axon Guidance Proteins
  18. Molecular signatures of basal cell carcinoma susceptibility and pathogenesis: A genomic approach
  19. West Nile virus diagnosis and vaccination: using unique viral peptide sequences to evoke specific immune responses
  20. Evidence for a vast peptide overlap between West Nile virus and human proteomes
  21. Homology, similarity, and identity in peptide epitope immunodefinition
  22. A qualitative description of the peptide sharing between poliovirus andHomo sapiens
  23. Editorial[Hot Topic: Peptides in Diagnosis and Therapy (Executive Guest Editor: Darja Kanduc)]
  24. Circumscribing the Conformational Peptide Epitope Landscape
  25. How a single amino acid change may alter the immunological information of a peptide
  26. Reviewing the role of peptide rarity in bacterial toxin immunomics
  27. Peptide cross-reactivity the original sin of vaccines
  28. A quantitative description of the peptide sharing between poliovirus andHomo sapiens
  29. HCV: Written in our DNA
  30. Selfness-nonselfness in designing an anti-B19 erythrovirus vaccine
  31. Searching for an effective, safe and universal anti-HIV vaccine: Finding the answer in just one short peptide
  32. Pentapeptide commonality betweenCorynebacterium diphtheriaetoxin and theHomo sapiensproteome
  33. No human protein is exempt from bacterial motifs, not even one
  34. Pentapeptide sharing betweenCorynebacterium diphtheriatoxin and the human neural protein network
  35. Describing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes
  36. The self/nonself issue: A confrontation between proteomes
  37. Protein information content resides in rare peptide segments
  38. Hepatitis B virus and Homo sapiens proteomewide analysis: A profusion of viral peptide overlaps in neuron-specific human proteins
  39. Clustering of rare peptide segments in the HCV immunome
  40. Proposing Low-Similarity Peptide Vaccines againstMycobacterium tuberculosis
  41. The oligodeoxynucleotide sequences corresponding to never-expressed peptide motifs are mainly located in the non-coding strand
  42. Bacterial peptides are intensively present throughout the human proteome
  43. “Self-Nonself” Peptides in the Design of Vaccines
  44. Codon number shapes peptide redundancy in the universal proteome composition
  45. Proteome-guided search for influenza A B-cell epitopes
  46. Proteome-based epitopic peptide scanning along PSA
  47. Rare peptide segments are found significantly more often in proto-oncoproteins than control proteins: implications for immunology and oncology
  48. Pentapeptide overlapping between human immunodeficiency viruses and Home sapiens proteomes is higher than 90%
  49. Epitopic peptides with low similarity to the host proteome: towards biological therapies without side effects
  50. Massive peptide sharing between viral and human proteomes
  51. Sequence uniqueness and sequence variability as modulating factors of human anti-HCV humoral immune response
  52. Correlating low-similarity peptide sequences and HIV B-cell epitopes
  53. Widespread and ample peptide overlapping between HCV and Homo sapiens proteomes
  54. Non-redundant Peptidomes from DAPs: Towards “The Vaccine”?
  55. Pre-eclampsia is associated with Helicobacter pylori seropositivity in Italy
  56. Genome-wide transcriptional profiling in human squamous cell carcinoma of the skin identifies unique tumor-associated signatures
  57. Defining Peptide Sequences: From Antigenicity to Immunogenicity Through Redundancy
  58. Peptimmunology: Immunogenic Peptides and Sequence Redundancy
  59. Definition of anti-tyrosinase MAb T311 linear determinant by proteome-based similarity analysis
  60. Computational peptide dissection of Melan-a/MART-1 oncoprotein antigenicity
  61. Identification of Monoclonal Anti-HMW-MAA Antibody Linear Peptide Epitope by Proteomic Database Mining
  62. NMR probing of in silico identification of anti-HPV16 E7 mAb linear peptide epitope
  63. Non-self-discrimination as a driving concept in the identification of an immunodominant HMW-MAA epitopic peptide sequence by autoantibodies from melanoma cancer patients
  64. Possible association between HPV16 E7 protein level and cytokeratin 19
  65. Clinical applications of DNA microarray analysis
  66. Cancer prevention and therapy: strategies and problems
  67. Role of MHC II affinity and molecular mimicry in defining anti-HER-2/neu MAb-3 linear peptide epitope
  68. Translational Regulation of Human Papillomavirus Type 16 E7 mRNA by the Peptide SEQIKA, Shared by Rabbit α1-Globin and Human Cytokeratin 7
  69. Monoclonal and polyclonal humoral immune response to EC HER-2/NEU peptides with low similarity to the host's proteome
  70. Fractionation of Rat Liver tRNA by Reversed-Phase High Performance Liquid Chromatography: Isolation of ISO-tRNAsPro
  71. tRNA fractionation by HPLC
  72. Immunogenicity in Peptide-Immunotherapy: From Self/Nonself to Similar/Dissimilar Sequences